Interestingly, the effect of the tumor-activated versus control SCs on SCLC cell invasiveness was significantly higher, and this was associated with a higher level of expression of several genes, including the STAT3, SOCS3, BCL6, ELF3, IGF2, and IL32 genes, in SCLC cells. The gene discussed is STAT3; the disease is small cell lung carcinoma.